https://clinicaltrials.gov/ct2/show/NCT03933943?type=Intr&cond=Lupus&phase=012345&lupd_s=04%2F17%2F2019&lupd_d=14
Condition : Lupus Erythematosus, Systemic
Interventions : Drug: LY3361237; Drug: Placebo
Sponsor : Eli Lilly and Company
Not yet recruiting
A Study of LY3361237 in Participants With Systemic Lupus Erythematosus
NCT03933943
Wed, 01 May 2019 12:00:00 EDT
